Compared with older interferon-based therapy, modern DAA treatment is generally much easier to tolerate. Some people may still experience fatigue, headache, nausea, or sleep changes, usually mild to moderate. A major practical risk is drug interactions, which can affect antiviral exposure or increase side effects. That is why a full medication review—including supplements—should be completed and monitored by a clinician during therapy.